The Gellman analysis

gan Matheson, D. C.
Cyhoeddwyd 1972

Manometric evaluation of rectal prolapse and faecal incontinence.

gan Matheson, D M, Keighley, M R
Cyhoeddwyd 1981

Fluothane and Other Non-Explosive Halogenated Hydrocarbons in Clinical Anæsthesia

gan Dixon, G. D., Matheson, D. I.
Cyhoeddwyd 1958

Enuresis: A Three-Year Study of the Value of a Waking Apparatus

gan McKendry, J. B. J., Williams, H. A., Matheson, D.
Cyhoeddwyd 1964

Innate and adaptive immune gene expression profiles as biomarkers in human type 1 diabetes

gan Han, D, Cai, X, Wen, J, Matheson, D, Skyler, J S, Kenyon, N S, Chen, Z
Cyhoeddwyd 2012

Further studies of natural killer cell function in Chediak-Higashi patients.

gan Roder, J C, Haliotis, T, Laing, L, Kozbor, D, Rubin, P, Pross, H, Boxer, L A, White, J G, Fauci, A S, Mostowski, H, Matheson, D S
Cyhoeddwyd 1982

Use of self-collected capillary blood samples for islet autoantibody screening in relatives: a feasibility and acceptability study

gan Liu, Y., Rafkin, L. E., Matheson, D., Henderson, C., Boulware, D., Besser, R. E. J., Ferrara, C., Yu, L., Steck, A. K., Bingley, P. J.
Cyhoeddwyd yn Diabet Med (2017)

POSEIDON study: a pilot, safety and feasibility trial of high-dose omega3 fatty acids and high-dose cholecalciferol supplementation in type 1 diabetes

gan Baidal, D. A., Sanchez, J., Alejandro, R., Blaschke, C. E., Hirani, K., Matheson, D. L., Messinger, S., Pugliese, A., Rafkin, L. E., Roque, L. A., Vera Ortiz, J. M., Ricordi, C.
Cyhoeddwyd yn CellR4 Repair Replace Regen Reprogram (2018)

Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol

gan Sydes, M R, Spears, M R, Mason, M D, Clarke, N W, Dearnaley, D P, de Bono, J S, Attard, G, Chowdhury, S, Cross, W, Gillessen, S, Malik, Z I, Jones, R, Parker, C C, Ritchie, A W S, Russell, J M, Millman, R, Matheson, D, Amos, C, Gilson, C, Birtle, A, Brock, S, Capaldi, L, Chakraborti, P, Choudhury, A, Evans, L, Ford, D, Gale, J, Gibbs, S, Gilbert, D C, Hughes, R, McLaren, D, Lester, J F, Nikapota, A, O’Sullivan, J, Parikh, O, Peedell, C, Protheroe, A, Rudman, S M, Shaffer, R, Sheehan, D, Simms, M, Srihari, N, Strebel, R, Sundar, S, Tolan, S, Tsang, D, Varughese, M, Wagstaff, J, Parmar, M K B, James, N D
Cyhoeddwyd yn Ann Oncol (2018)

Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy

gan James, N.D., de Bono, J.S., Spears, M.R., Clarke, N.W., Mason, M.D., Dearnaley, D.P., Ritchie, A.W.S., Amos, C.L., Gilson, C., Jones, R.J., Matheson, D., Millman, R., Attard, G., Chowdhury, S., Cross, W.R., Gillessen, S., Parker, C.C., Russell, J.M., Berthold, D.R., Brawley, C., Adab, F., Aung, S., Birtle, A.J., Bowen, J., Brock, S., Chakraborti, P., Ferguson, C., Gale, J., Gray, E., Hingorani, M., Hoskin, P.J., Lester, J.F., Malik, Z.I., McKinna, F., McPhail, N., Money-Kyrle, J., O’Sullivan, J., Parikh, O., Protheroe, A., Robinson, A., Srihari, N.N., Thomas, C., Wagstaff, J., Wylie, J., Zarkar, A., Parmar, M.K.B., Sydes, M.R.
Cyhoeddwyd yn N Engl J Med (2017)

Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial

gan Clarke, N W, Ali, A, Ingleby, F C, Hoyle, A, Amos, C L, Attard, G, Brawley, C D, Calvert, J, Chowdhury, S, Cook, A, Cross, W, Dearnaley, D P, Douis, H, Gilbert, D, Gillessen, S, Jones, R J, Langley, R E, MacNair, A, Malik, Z, Mason, M D, Matheson, D, Millman, R, Parker, C C, Ritchie, A W S, Rush, H, Russell, J M, Brown, J, Beesley, S, Birtle, A, Capaldi, L, Gale, J, Gibbs, S, Lydon, A, Nikapota, A, Omlin, A, O'Sullivan, J M, Parikh, O, Protheroe, A, Rudman, S, Srihari, N N, Simms, M, Tanguay, J S, Tolan, S, Wagstaff, J, Wallace, J, Wylie, J, Zarkar, A, Sydes, M R, Parmar, M K B, James, N D
Cyhoeddwyd yn Ann Oncol (2019)